Botanical species · safety record

Mikania laevigata

The EFSA Compendium of Botanicals holds 10 constituent measurements for Mikania laevigata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Mikania laevigata Sch.Bip. ex Baker

10Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Cardiac glycosides	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Coumarin	Leaves	Solvent extraction	≤ 0.94 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Coumarin	Unspecified	Solvent extraction	3.83 Percent	GC-MS	Resolve DOI
Coumarin	Leaves	Solvent extraction	≥ 0.18 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Coumarins	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Tannins	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Coumarin	Leaves	Solvent extraction	≥ 2.64 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Coumarin	Leaves	Solvent extraction	≤ 7.73 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Saponins	Leaves	Solvent extraction	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Medeiros Mazzorana, Daliane., Nicolau, Vanessa., Moreira, Jeverson., de Aguiar Amaral, Patricia., de Andrade, Vanessa Moraes. Influence of Mikania laevigata Extract over the Genotoxicity Induced by Alkylating Agents.. ISRN toxicology, 2013, vol. 2013, p. 521432-521432. DOI
Biavatti, MW., Koerich, CA., Henck, CH., Zucatelli, E., Martineli, FH., Bresolin, TB., Leite, SN. Coumarin content and physicochemical profile of Mikania laevigata extracts. ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 2004, vol. 59, no. 3-4, p. 197-200.
Bertolucci, Suzan Kelly V., Pereira, Ana Barbara D., Pinto, Jose Eduardo B. P., Oliveira, Alaide B., Braga, Fernao C. Seasonal Variation on the Contents of Coumarin and Kaurane-Type Diterpenes in Mikania laevigata and M. glomerata Leaves under Different Shade Levels. CHEMISTRY & BIODIVERSITY, 2013, vol. 10, no. 2, p. 288-295. DOI
Graca, Carlos., Baggio, Cristiane Hatsuko., Freitas, Cristina Setim., Rattmann, Yanna Dantas., de Souza, Lauro Mera., Cipriani, Thales Ricardo., Sassaki, Guilherme Lanzi., Rieck, Lia., Pontarolo, Roberto., da Silva-Santos, Jose Eduardo., Andrade Marques, Maria Consuelo. In vivo assessment of safety and mechanisms underlying in vitro relaxation induced by Mikania laevigata Schultz Bip. ex Baker in the rat trachea. JOURNAL OF ETHNOPHARMACOLOGY, 2007, vol. 112, no. 3, p. 430-439. DOI
Lima, N. P., Biasi, L. A., Zanette, F., Nakashima, T. Guaco (Mikania glomerata Sprengel e Mikania laevigata Schultz Bip. Ex Baker) semi hardwood cutting and secondary metabolites production. . Revista brasileira de plantas medicinais, 2003, vol. 5, no. 2, p. 47-54.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature